A cancer detection platform which measures telomerase activity from live circulating tumor cells captured on a microfilter.
Ontology highlight
ABSTRACT: Circulating tumor cells (CTC) quantified in cancer patients' blood can predict disease outcome and response to therapy. However, the CTC analysis platforms commonly used cannot capture live CTCs and only apply to tumors of epithelial origin. To address these limitations, we have developed a novel cancer detection platform which measures telomerase activity from live CTCs captured on a parylene-C slot microfilter. Using a constant low-pressure delivery system, the new microfilter platform was capable of cell capture from 1 mL of whole blood in less than 5 minutes, achieving 90% capture efficiency, 90% cell viability, and 200-fold sample enrichment. Importantly, the captured cells retained normal morphology by scanning electron microscopy and could be readily manipulated, further analyzed, o
SUBMITTER: Xu T
PROVIDER: S-EPMC2922429 | biostudies-literature | 2010 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA